277 results on '"Barnes, Edward L."'
Search Results
2. Antibiotic Use in the 12 Months Prior to Ileal Pouch-Anal Anastomosis Increases the Risk for Pouchitis
3. Acute Kidney Injury in Inflammatory Bowel Disease Patients: A Nationwide Comparative Analysis
4. Suboptimal Guideline Adherence and Biomarker Underutilization in Monitoring of Post-operative Crohn’s Disease
5. Very Early Pouchitis Is Associated with an Increased Likelihood of Chronic Inflammatory Conditions of the Pouch
6. Real-World Surgical and Endoscopic Recurrence Based on Risk Profiles and Prophylaxis Utilization in Postoperative Crohn’s Disease
7. Comparative Effectiveness of Upadacitinib vs Ustekinumab for Ulcerative Colitis: A Multicenter Retrospective Cohort Study
8. AGA Clinical Practice Guideline on the Management of Pouchitis and Inflammatory Pouch Disorders
9. Development of an Inflammatory Bowel Disease-Specific Medication Adherence Instrument and Reasons for Non-adherence
10. Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease With Active or Recent Malignancy: A Multi-Center Cohort Study
11. Development of the Endoscopic Pouch Score for Assessment of Inflammatory Conditions of the Pouch
12. Relationship Between Stages of Ileal Pouch-Anal Anastomosis, Timing of Restoration of Fecal Continuity, and Pouchitis
13. Patient Reported Outcome Assessments Used in the Evaluation of Patients after Ileal Pouch-Anal Anastomosis: A Systematic Review
14. Increasing Incidence of Pouchitis Between 1996 and 2018: A Population-Based Danish Cohort Study
15. Patients With Pouchitis Demonstrate a Significant Cost Burden in the First Two Years After Ileal Pouch-Anal Anastomosis
16. Test Characteristics of Cross-sectional Imaging and Concordance With Endoscopy in Postoperative Crohn’s Disease
17. Predictors and Outcomes of Ustekinumab Dose Intensification in Ulcerative Colitis: A Multicenter Cohort Study
18. The Natural History After Ileal Pouch-Anal Anastomosis for Ulcerative Colitis: A Population-Based Cohort Study From the United States.
19. Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021
20. Postoperative Use of Biologics Was Less Common Among Patients With Crohn’s Disease With Emergent/Urgent vs Elective Intestinal Resection
21. Single-Cell Analysis Reveals Unexpected Cellular Changes and Transposon Expression Signatures in the Colonic Epithelium of Treatment-Naïve Adult Crohn’s Disease Patients
22. Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD
23. Incidence, Risk Factors, and Outcomes of Pouchitis and Pouch-Related Complications in Patients With Ulcerative Colitis
24. Creation of a Case-Finding Definition for Identifying Patients With Acute Pouchitis in Administrative Claims Data
25. Drug-induced liver injury associated with lopinavir-ritonavir in patients with COVID-19: a disproportionality analysis of U.S. food and drug administration adverse event reporting system (FAERS) data
26. Efficacy and Safety of Liraglutide in Patients With an Ileal Pouch-Anal Anastomosis and Chronic High Bowel Frequency: A Placebo-Controlled, Crossover, Proof-of-Concept Study.
27. Change in Biologic Class Promotes Endoscopic Remission Following Endoscopic Postoperative Crohn's Disease Recurrence.
28. One-Year Comparative Effectiveness of Upadacitinib vs Tofacitinib for Ulcerative Colitis: A Multicenter Cohort Study.
29. Patients With Inflammatory Bowel Disease Are at Increased Risk of Hospitalization Due to Respiratory Syncytial Virus.
30. Extensive Colitis and Smoking Are Associated With Postoperative Complications Within 30 Days of Ileal Pouch–Anal Anastomosis.
31. A Practical Guide to the Use of Upadacitinib in Ulcerative Colitis and Crohn's Disease.
32. Clinical and Endoscopic Outcomes After Upadacitinib Induction for Ulcerative Colitis: A Multicenter Retrospective Cohort Study.
33. Perioperative and Postoperative Management of Patients With Crohn’s Disease and Ulcerative Colitis
34. Decreased Colonic Activin Receptor-Like Kinase 1 Disrupts Epithelial Barrier Integrity in Patients With Crohn’s Disease
35. The Cumulative Incidence of Pouchitis in Pediatric Patients With Ulcerative Colitis
36. Antibiotic Use Patterns in the Management of Chronic Pouchitis
37. Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States
38. The Pouch Corner: A Review of Functional Pouch Disorders.
39. In Acute Severe Ulcerative Colitis Patients Who Receive Rescue Therapy, Prior Maintenance Therapy and Day 3 C-Reactive Protein After Rescue Therapy Are Associated With 12-Month Colectomy Risk.
40. Increased colonic expression of ACE2 associates with poor prognosis in Crohn’s disease
41. Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018
42. The Ileal Pouch-Anal Anastomosis: Identifying Structural Disorders.
43. Factors Associated With Performing IPAA After Total Colectomy for Ulcerative Colitis.
44. Clinical Decision Making in Inflammatory Bowel Disease Mimics: Practice Management from Inflammatory Bowel Disease LIVE.
45. Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis
46. The Burden of Hospital Readmissions among Pediatric Patients with Inflammatory Bowel Disease
47. High Dietary Intake of Specific Fatty Acids Increases Risk of Flares in Patients With Ulcerative Colitis in Remission During Treatment With Aminosalicylates
48. A Practical Guide to the Use of Mirikizumab.
49. Changes in Therapy Are Not Associated With Increased Remission in Patients With Crohn's Disease of the Pouch.
50. The Safety of Dilation of Ileoanal Strictures With Mechanical or Balloon Dilation Is Similar Among Patients After Ileal Pouch–Anal Anastomosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.